Works matching AU Schäfer-Korting, M.

Results: 18

In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans.

Published in:

Mycoses, 2006, v. 49, n. 3, p. 159, doi. 10.1111/j.1439-0507.2006.01228.x

By:

Sigle, H. C.;
Schäfer-Korting, M.;
Korting, H. C.;
Hube, B.;
Niewerth, M.

Publication type:

Article

Improving Topical Non-Melanoma Skin Cancer Treatment: In vitro Efficacy of a Novel Guanosine-Analog Phosphonate.

Published in:

Skin Pharmacology & Physiology, 2014, v. 27, n. 4, p. 173, doi. 10.1159/000354118

By:

ali-von Laue, C.;
Zoschke, C.;
Do, N.;
Lehnen, D.;
Küchler, S.;
Mehnert, W.;
Blaschke, T.;
Kramer, K.D.;
Plendl, J.;
Weindl, G.;
Korting, H.C.;
Hoeller Obrigkeit, D.;
Merk, H.-F.;
Schäfer-Korting, M.

Publication type:

Article

Morphine Metabolism in Human Skin Microsomes.

Published in:

Skin Pharmacology & Physiology, 2012, v. 25, n. 6, p. 319, doi. 10.1159/000342067

By:

Heilmann, S.;
Küchler, S.;
Schäfer-Korting, M.

Publication type:

Article

Antimicrobial Peptides and Skin: A Paradigm of Translational Medicine.

Published in:

Skin Pharmacology & Physiology, 2012, v. 25, n. 6, p. 323, doi. 10.1159/000341990

By:

Korting, H.C.;
Schöllmann, C.;
Stauss-Grabo, M.;
Schäfer-Korting, M.

Publication type:

Article

Stabilization of Reactive Nitroxides Using Invasomes to Allow Prolonged Electron Paramagnetic Resonance Measurements.

Published in:

Skin Pharmacology & Physiology, 2011, v. 24, n. 6, p. 312, doi. 10.1159/000330235

By:

Haag, S.F.;
Taskoparan, B.;
Bittl, R.;
Teutloff, C.;
Wenzel, R.;
Fahr, A.;
Chen, M.;
Lademann, J.;
Schäfer-Korting, M.;
Meinke, M.C.

Publication type:

Article

Drug Release and Skin Penetration from Solid Lipid Nanoparticles and a Base Cream: A Systematic Approach from a Comparison of Three Glucocorticoids.

Published in:

Skin Pharmacology & Physiology, 2011, v. 24, n. 4, p. 199, doi. 10.1159/000324053

By:

Schlupp, P.;
Blaschke, T.;
Kramer, K. D.;
Höltje, H.-D.;
Mehnert, W.;
Schäfer-Korting, M.

Publication type:

Article

Experimentelle Modelle humaner Hautalterung.

Published in:

Der Hautarzt, 2016, v. 67, n. 2, p. 93, doi. 10.1007/s00105-015-3747-1

By:

Nikolakis, G.;
Zoschke, C.;
Makrantonaki, E.;
Hausmann, C.;
Schäfer-Korting, M.;
Zouboulis, C.

Publication type:

Article

Clinical Experience with Atenolol in Patients with Chronic Liver Disease.

Published in:

1983

By:

KIRCH, W.;
SCHÄFER-KORTING, M.;
MUTSCHLER, E.;
OHNHAUS, E. E.;
BRAUN, W.

Publication type:

Other

Glucocorticoids mediate differential anti-apoptotic effects in human fibroblasts and keratinocytes via sphingosine-1-phosphate formation (B. Kleuser and M. Schäfer-Korting contributed equally to this study.).

Published in:

Journal of Cellular Biochemistry, 2004, v. 91, n. 4, p. 840, doi. 10.1002/jcb.10766

By:

S. Hammer;
B. Sauer;
I. Spika;
C. Schraut;
B. Kleuser;
M. Schäfer-Korting

Publication type:

Article

Discrimination of the toxic potential of chemically differing topical glucocorticoids using a neutral red release assay with human keratinocytes and fibroblasts.

Published in:

British Journal of Dermatology, 1995, v. 133, n. 1, p. 54, doi. 10.1111/1365-2133.ep14843045

By:

Korting, H. C.;
Hülsebus, E.;
Kerscher, M.;
Greber, R.;
Schäfer-Korting, M.

Publication type:

Article

Glucocorticoids for Human Skin: New Aspects of the Mechanism of Action.

Published in:

Skin Pharmacology & Physiology, 2005, v. 18, n. 3, p. 103, doi. 10.1159/000084907

By:

M. Schäfer-Korting;
B. Kleuser;
M. Ahmed;
H.-D. Höltje;
H.C. Korting

Publication type:

Article

Cutaneous Estradiol Permeation, Penetration and Metabolism in Pig and Man.

Published in:

Skin Pharmacology & Physiology, 2005, v. 18, n. 1, p. 27, doi. 10.1159/000081683

By:

A. Mahmoud;
A. Haberland;
M. Dürrfeld;
D. Heydeck;
S. Wagner;
M. Schäfer-Korting

Publication type:

Article

Safety and Efficacy of Fluticasone Propionate in the Topical Treatment of Skin Diseases.

Published in:

Skin Pharmacology & Physiology, 2005, v. 18, n. 1, p. 3, doi. 10.1159/000081680

By:

A. Roeder;
M. Schaller;
M. Schäfer-Korting;
H.C. Korting

Publication type:

Article

Tazarotene: Therapeutic Strategies in the Treatment of Psoriasis, Acne and Photoaging.

Published in:

Skin Pharmacology & Physiology, 2004, v. 17, n. 3, p. 111, doi. 10.1159/000077236

By:

A. Roeder;
M. Schaller;
M. Schäfer-Korting;
H.C. Korting

Publication type:

Article

In silico models to predict dermal absorption from complex agrochemical formulations.

Published in:

SAR & QSAR in Environmental Research, 2014, v. 25, n. 7, p. 565, doi. 10.1080/1062936X.2014.919358

By:

Guth, K.;
Riviere, J.E.;
Brooks, J.D.;
Dammann, M.;
Fabian, E.;
van Ravenzwaay, B.;
Schäfer-Korting, M.;
Landsiedel, R.

Publication type:

Article

Qualitative and Quantitative Assessment of the Benefit-Risk Ratio of Medium Potency Topical Corticosteroids In Vitro and In Vivo: Characterisation of Drugs with an Increased Benefit-Risk Ratio.

Published in:

BioDrugs, 2000, v. 13, n. 4, p. 267, doi. 10.2165/00063030-200013040-00005

By:

Schackert, C.;
Korting, H.C.;
Schäfer-Korting, M.

Publication type:

Article

Drug Targeting by Solid Lipid Nanoparticles for Dermal Use.

Published in:

Journal of Drug Targeting, 2002, v. 10, n. 6, p. 489, doi. 10.1080/1061186021000038364

By:

Maia, C. Santos;
Mehnert, W.;
Schaller, M.;
Korting, H. C.;
Gysler, A.;
Haberland, A.;
Schäfer-Korting, M.

Publication type:

Article

Sphingosine-1-Phosphate Cross-Activates the Smad Signaling Cascade and Mimics TGFβ-Induced Cell Responses.

Published in:

Kidney & Blood Pressure Research, 2004, v. 27, n. 5/6, p. 403

By:

Huwiler, A.;
Xin, C.;
Ren, S.;
Kleuser, B.;
Shabahang, S.;
Eberhardt, W.;
Radeke, H.;
Schäfer-Korting, M.;
Pfeilschifter, J.

Publication type:

Article